Jacquiline Habashy, DO
Dermatology · Beverly Hills, CANPI 1225497464
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $129,400 of the $142,876 with a category attached, or 90.6%. Galderma Laboratories, L.p. accounts for 93.6% of it on its own, with 26 other manufacturers making up the rest. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 352 payments — averaging $405.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$134K
- AbbVie$3K
- Amgen$1K
- Regeneron Healthcare Solutions, Inc.$766
- Sun Pharmaceutical Industries Inc.$559
- Novartis$483
- plus $3K from 21 others
What the payments were for
- Speaking & faculty fees$129,40091%
- Travel & lodging$1,5451%
- Food & beverage$11,8318%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 132 | $133,786 |
| AbbVie(2 entities) | 75 | $2,647 |
| Amgen | 30 | $1,347 |
| Regeneron Healthcare Solutions, Inc. | 8 | $766 |
| Sun Pharmaceutical Industries Inc. | 14 | $559 |
| Novartis | 10 | $483 |
| Bristol Myers Squibb | 7 | $471 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $384 |
| Sanofi | 7 | $294 |
| Johnson & Johnson | 12 | $272 |
| Lilly USA, LLC | 9 | $252 |
| Journey Medical Corporation | 5 | $245 |
| Janssen Scientific Affairs, LLC | 2 | $237 |
| Solta Medical, A Division Of Bausch Health US, LLC | 2 | $211 |
| Almirall LLC | 2 | $146 |
| LEO Pharma Inc. | 7 | $145 |
| Revance Therapeutics, Inc. | 3 | $123 |
| Dermira, Inc. | 1 | $123 |
| Mayne Pharma Commercial LLC | 8 | $122 |
| Incyte Corporation | 3 | $49 |
| Regeneron | 1 | $45 |
| EPI Health, LLC | 2 | $38 |
| Pfizer | 2 | $33 |
| UCB, Inc. | 1 | $32 |
| Organon | 1 | $28 |
| VYNE Pharmaceuticals Inc. | 1 | $19 |
| Merz North America, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$142,876 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 24 | $280 |
| Triamcinolone Acetonide | 20 | $191 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Beverly Hills
- Paul WallaceBeverly Hills$388K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.